Print


ISIN and CFI Database for Non-Russian Financial Instruments that Meet the Requirements of Bank of Russia Regulation on Qualification

The Database contains ISIN and CFI codes allocated by authorized agencies in accordance with ISO 6166 and ISO 10962, and the CFI codes meet the requirements of paragraph 4.2 of the Directive of the Central Bank of the Russian Federation No. 4561-U dated October 3, 2017 "On the Procedure for the Qualification of Foreign Financial Instruments as Securities" (in the version of the Directive of Bank of Russia No. 4903-U dated 12.09.2018).

Information on non-Russian financial instruments is updated in real time as a result of processing clients' new requests relating to new instruments, and upon completion of NSD's daily monitoring of information on instruments already recorded in the Database.

Information on ISIN and CFI codes is provided by NSD to market participants solely for the purpose of qualification of non-Russian financial instruments as securities admitted for operations on the Russian market*.

 
Search key:
 
27221-27240 of 80001 results shown.
ISIN Issuer; Country Issue Description CFI Code Edition of IS0 10962 ISIN Status [?] Numbering Agency Information Source As of
US03211P2020 AMPLIPHI BIOSCIENCES CORP; US COM NEW ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03211P3010 AMPLIPHI BIOSCIENCES CORP; US COM PAR $0.001 ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03211Q2003 AMPLITECH GROUP INC.; US COM NEW ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US03212A1051 AMPLITUDE HEALTHCARE ACQUISITION CORP; US CL A ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-10-01
US03212B1035 AMPLIFY ENERGY CORP NEW; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03213A1043 AMPLITUDE INC; US COM CL A ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03214Q1085 AMPRIUS TECHNOLOGIES INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US0321591051 AMREP CORP; US COM ESVUFR 2015 New Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03216B2088 AMREIT INC NEW; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03217CAA45 AMS-OSRAM AG; AT SR NT 144A DBFNGR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2022-02-11
US03217L1061 AMRYT PHARMA PLC; GB SPONSORED ADR EDSXFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03232P4054 AMSURG CORP; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03232Q1067 AMTEC INC; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0323325045 AMTECH SYS INC; US COM PAR $0.01 NEW ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03233Q1058 AMTEK AUTO LTD; IN SPONSORED GDR EDSXFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0323593097 AMTRUST FINL SVCS INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03235R1014 AMTEL N V; NL SPONSORED GDR REG S EDSXFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03236M1018 AMYRIS INC; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03236M2008 AMYRIS INC; US COM NEW ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US03237H1014 AMYLYX PHARMACEUTICALS INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10

* NSD does not make any representation or warranty as to the completeness or reliability of the information contained herein, nor does it make any warranty regarding its consistency with the purposes for which the information is used, including but not limited to, commercial purposes. The information published on this website is not to be construed as an offer to effect any deal with financial instruments, and should not be used for commercial or other purposes; nor does it represent an offer from NSD to render any services; nor does it make any warranty or representation of reliability of certain financial instruments or persons (including but not limited to, issuers, securities market participants, etc.).


For further information, please refer to NSD’s experts.

Printed version

Print